Provenge Extends Life of Prostate Cancer Patients, Study Finds
Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo.
Month: April 2009
Microline PENTAX Acquires Starion Instruments
Two strong players in the surgical-instrument field have joined forces. Microline PENTAX, a leading manufacturer of reposable surgical instruments for laparoscopic procedures, has acquired California-based Starion Instruments, a developer of instruments to arrest bleeding during surgical procedures.
Isto Gets Go-Ahead for Clinical Study of NuQu
ISTO Technologies has received FDA approval to begin a Phase I clinical study for NuQu, an injectable formulation of juvenile cartilage cells designed to treat chronic back pain caused by degenerative disc disease.
Thermo Fisher to Acquire Biolab
Thermo Fisher Scientific, a developer of analytical instruments and research products, has announced plans to acquire Biolab for $120 million.
Major Milestone for Sunshine Heart
Sunshine Heart, a global company that develops cardiac assist devices, has successfully completed the first two implants of the company’s C-Pulse heart assist system under a 20-person clinical trial approved by the U.S. Food and Drug Administration.
First Patient Successfully Treated With Algisyl-LVR Device
Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient.
[Company Profile] ScyFix Combats Age-Related Vision Loss
The idea of putting electrodes on one’s eyelids might cause many to cringe, but ScyFIX of Minnesota is turning this odd concept into a promising treatment for age-related vision loss.
Medtech Insight European Medical Device Conference: April 29-30, 2009
Join medical technology company investors and acquirers and secure your spot at the Leading Medical Device Strategic Partnering and Investment Event in Paris, France. Don’t […]
Pantec Reports Success In Transdermal Patch Trials
Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory.
GlaxoSmithKline, Pfizer Team Up Against HIV
The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.